| Breakdown | TTM | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | -138.80M | -198.06M | 235.19M | -2.23M | -132.47M | 484.37M |
| Gross Profit | 51.70M | -205.14M | 208.14M | 34.33M | -132.67M | 536.51M |
| EBITDA | -153.50M | -209.17M | 0.00 | 15.63M | -130.72M | 486.20M |
| Net Income | -168.47M | -209.77M | 201.16M | -8.79M | -141.53M | 477.02M |
Balance Sheet | ||||||
| Total Assets | 1.52B | 1.78B | 2.19B | 2.25B | 2.42B | 2.48B |
| Cash, Cash Equivalents and Short-Term Investments | 31.27M | 93.58M | 73.80M | 58.92M | 26.59M | 29.59M |
| Total Debt | 0.00 | 68.07M | 68.94M | 55.93M | 113.60M | 49.90M |
| Total Liabilities | 74.17M | 97.39M | 112.79M | 99.21M | 153.22M | 101.24M |
| Stockholders Equity | 1.44B | 1.68B | 2.08B | 2.15B | 2.27B | 2.38B |
Cash Flow | ||||||
| Free Cash Flow | -3.92M | -1.54M | 2.26M | 5.39M | -13.33M | 931.00K |
| Operating Cash Flow | -3.92M | -1.54M | 2.26M | 5.39M | -13.33M | 931.00K |
| Investing Cash Flow | 430.98M | 223.38M | 279.14M | 197.24M | -82.68M | -225.28M |
| Financing Cash Flow | -365.10M | -201.18M | -279.59M | -112.58M | 30.11M | 363.85M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
63 Neutral | £833.54M | 2.30 | 8.81% | ― | 11.00% | ― | |
54 Neutral | ― | 8.06 | -9.17% | 0.63% | -156.60% | -180.02% | |
52 Neutral | £14.68M | -2.82 | -16.69% | ― | 30.40% | 23.48% | |
51 Neutral | $7.86B | -0.30 | -43.30% | 2.27% | 22.53% | -2.21% | |
50 Neutral | £483.23M | 8.09 | 7.16% | ― | ― | 33.10% | |
44 Neutral | £70.26M | 1.56 | -12.24% | ― | ― | -600.00% | |
43 Neutral | £11.95M | -0.87 | -14.62% | ― | -9.22% | -386.93% |